About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill
October 27, 2021 |
Brittany Herrick
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
Merck expands manufacturing for molnupiravir. But questions remain.
Related Posts
Access to Medicines
Pharma Pricing Secrecy Run...
Funding the Fight
Congress’s Spending Bill...
Health Justice
PEPFAR can’t kee...